Permanent Unwanted Tattoo Removal by Tattoo Expert

Permanent Unwanted Tattoo Removal by Tattoo Expert
Safely, Painlessly, Laserlessly and Naturally in Removing any Unwanted Tattoos in 2 to 8 Weeks, Guaranteed

Monday, September 5, 2016

Women Health: Menstrual Disorders - Secondary menorrhagia Non-hormonal treatment- Cyklokapron (tranexamic acid) in Conventional medicine Perspective

Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

Menorrhagia is defined as a condition of excessive bleeding in the menstruation phase of the menstrual cycle in the reproductive age of a woman leading to heavy blood loss that can interfere with the woman normal activities, as a result of disruption of normal hormonal regulation of periods or disorders of certain reproductive organs.


                 The Non-hormonal treatment- Cyklokapron (tranexamic acid )

The medication has been used widely to reduce short-term in people up to 50% with a certain type of bleeding disorder, including menorrhagia.
2. According to the article of Cyklokapron posted in Drug.com
Risks and Side effects of Cyklokapron Injection include
a. In patients with acquired defective color vision, since this prohibits measuring one endpoint that should be followed as a measure of toxicity
b. In patients with subarachnoid hemorrhage. Anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by Cyklokapron in such patients.
c. In patients with active intravascular clotting.
d. In patients with hypersensitivity to tranexamic acid or any of the ingredients.

No comments:

Post a Comment